You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Chlorthalidone - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for chlorthalidone and what is the scope of patent protection?

Chlorthalidone is the generic ingredient in nine branded drugs marketed by Abbott, Ajanta Pharma Ltd, Alembic, Alkem Labs Ltd, Amneal Pharms Co, Ani Pharms, Appco, Ascot, Barr Labs Inc, Chartwell Rx, Cosette, Dava Pharms Inc, Inventia, Ivax Pharms, Kv Pharm, Mankind Pharma, Mutual Pharm, Mylan, Novast Labs, Pioneer Pharms, Purepac Pharm, Sandoz, Sun Pharm Industries, Sunny, Superpharm, Tagi, Umedica, Unichem, Usl Pharma, Vangard, Warner Chilcott, Watson Labs, Zydus Pharms, Sanofi Aventis Us, Casper Pharma Llc, Monarch Pharms, Par Pharm, Boehringer Ingelheim, and Novartis, and is included in sixty-eight NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for chlorthalidone. Thirty-five suppliers are listed for this compound.

Summary for chlorthalidone

US Patents:	0
Tradenames:	9
Applicants:	39
NDAs:	68
Drug Master File Entries:	21
Finished Product Suppliers / Packagers:	35
Raw Ingredient (Bulk) Api Vendors:	106
Clinical Trials:	65
Patent Applications:	6,527
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for chlorthalidone
Drug Sales Revenues:	Drug sales revenues for chlorthalidone
What excipients (inactive ingredients) are in chlorthalidone?	chlorthalidone excipients list
DailyMed Link:	chlorthalidone at DailyMed

See drug prices for chlorthalidone

Drug Sales Revenue Trends for chlorthalidone

See drug sales revenues for chlorthalidone

Recent Clinical Trials for chlorthalidone

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Jessa Hospital	Phase 4
Vrije Universiteit Brussel	Phase 4
Roche Diagnostics	Phase 4

See all chlorthalidone clinical trials

Pharmacology for chlorthalidone

Drug Class	Thiazide-like Diuretic
Physiological Effect	Increased Diuresis

Medical Subject Heading (MeSH) Categories for chlorthalidone

Antihypertensive Agents
Diuretics
Sodium Chloride Symporter Inhibitors

US Patents and Regulatory Information for chlorthalidone

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Purepac Pharm	CHLORTHALIDONE	chlorthalidone	TABLET;ORAL	088140-001	Aug 11, 1983		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	CHLORTHALIDONE	chlorthalidone	TABLET;ORAL	211063-002	Feb 26, 2019	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Ascot	CHLORTHALIDONE	chlorthalidone	TABLET;ORAL	087699-001	Oct 20, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Novartis	LOPRESSIDONE	chlorthalidone; metoprolol tartrate	CAPSULE;ORAL	019451-001	Dec 31, 1987		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Ani Pharms	CHLORTHALIDONE	chlorthalidone	TABLET;ORAL	088164-001	Jan 9, 1984		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Tagi	CHLORTHALIDONE	chlorthalidone	TABLET;ORAL	212878-001	Feb 24, 2022	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Sanofi Aventis Us	REGROTON	chlorthalidone; reserpine	TABLET;ORAL	015103-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for chlorthalidone

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Casper Pharma Llc	THALITONE	chlorthalidone	TABLET;ORAL	019574-001	Dec 20, 1988	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.